CM
AZN icon

Columbus Macro’s AstraZeneca AZN Stock Holding History

Columbus Macro’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Sell
15,923
-11
-0.1% -$2.07K 0.29% 104
2026
Q1 		$3.1M Sell
15,934
-152
-0.9% -$29.3K 0.33% 95
2025
Q4 		$2.96M Sell
16,086
-641
-4% -$112K 0.32% 97
2025
Q3 		$2.57M Buy
16,727
+164
+1% +$24.8K 0.29% 104
2025
Q2 		$2.31M Buy
16,563
+175
+1% +$24.5K 0.28% 110
2025
Q1 		$2.41M Buy
16,388
+42
+0.3% +$6.08K 0.32% 108
2024
Q4 		$2.14M Buy
16,346
+6,227
+62% +$872K 0.3% 110
2024
Q3 		$1.57M Sell
10,119
-355
-3% -$57.3K 0.57% 61
2024
Q2 		$1.63M Sell
10,474
-377
-3% -$56.7K 0.63% 48
2024
Q1 		$1.47M Sell
10,851
-465
-4% -$61.6K 0.56% 56
2023
Q4 		$1.53M Buy
11,316
+2,246
+25% +$292K 0.6% 52
2023
Q3 		$1.23M Sell
9,070
-606
-6% -$82.8K 0.52% 68
2023
Q2 		$1.37M Sell
9,676
-560
-5% -$82.4K 0.54% 57
2023
Q1 		$1.44M Sell
10,236
-11
-0.1% -$1.48K 0.54% 65
2022
Q4 		$1.39M Sell
10,247
-117
-1% -$14.7K 0.53% 68
2022
Q3 		$1.14M Buy
10,364
+48
+0.5% +$6.09K 0.47% 75
2022
Q2 		$1.36M Sell
10,316
-2,264
-18% -$297K 0.52% 69
2022
Q1 		$1.67M Buy
12,580
+770
+7% +$92.3K 0.57% 58
2021
Q4 		$1.38M Sell
11,810
-734
-6% -$86.4K 0.46% 71
2021
Q3 		$1.51M Buy
12,544
+2,553
+26% +$297K 0.5% 60
2021
Q2 		$1.2M Buy
9,991
+2,124
+27% +$233K 0.37% 79
2021
Q1 		$782K Sell
7,867
-1,187
-13% -$119K 0.24% 106
2020
Q4 		$905K Sell
9,054
-497
-5% -$52.6K 0.28% 97
2020
Q3 		$1.05M Buy
+9,551
New +$1.06M 0.32% 84

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Columbus Macro's AZN Position: Q2 2026 in Review

Columbus Macro reduced its AstraZeneca (AZN) stake by 0.07% in Q2 2026, selling an estimated $2.07K and leaving 15,923 shares worth $2.99M. The position accounts for 0.29% of the portfolio, ranked #104.

Columbus Macro first reported a position in AZN in Q3 2020 and has held it in 24 quarters since. The position peaked at $3.1M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Columbus Macro held 15,923 shares of AstraZeneca worth $2.99M as of Q2 2026.
  • Columbus Macro sold 11 AstraZeneca shares in Q2 2026, an estimated $2.07K.
  • AstraZeneca made up 0.29% of Columbus Macro's portfolio in Q2 2026, its #104 holding.
  • Columbus Macro first reported a position in AstraZeneca in Q3 2020 and has held it in 24 quarters since.
  • Columbus Macro's AstraZeneca position peaked at $3.1M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Columbus Macro's 13F filing for Q2 2026, filed 22 Jul 2026.